يعرض 1 - 10 نتائج من 86 نتيجة بحث عن '"Adra, N"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المساهمون: University of Washington Seattle, Fred Hutchinson Cancer Research Center Seattle (FHCRC), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Passeig Vall d'Hebron Barcelona, Spain, Memorial Sloane Kettering Cancer Center New York, University of Iowa Iowa City, Studienpraxis Urologie Nürtingen, Germany, Comprehensive Cancer Centers Las Vegas, NV, USA, MD Anderson Cancer Center Madrid, Spain, Indiana State University, Department of Internal Medicine and Computational Medicine and Bioinformatics Ann Arbor, MI, USA, University of Michigan Ann Arbor, University of Michigan System-University of Michigan System, Human Tumor Immunobiology Unit Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute Milan, IMIM-Hospital del Mar, Generalitat de Catalunya = Generalidad de Cataluña = Government of Catalonia, Huntsman Cancer Institute Salt Lake City, University of Utah, Guy's and St Thomas NHS Foundation Trust London, Stanford University, Clovis Oncology, Inc. Boulder, CO, USA

    المصدر: ISSN: 1471-2407.

  7. 7
    دورية أكاديمية

    المساهمون: Medicine, School of Medicine

    المصدر: PMC

    وصف الملف: application/pdf

    العلاقة: BMC Cancer; Grivas P, Loriot Y, Morales-Barrera R, et al. Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS). BMC Cancer. 2021;21(1):593. Published 2021 May 24. doi:10.1186/s12885-021-08085-z; https://hdl.handle.net/1805/30187Test

  8. 8
    دورية أكاديمية

    المصدر: 35th Anniversary Annual Meeting (SITC 2020)

    العلاقة: Dorff, T., Rettig, M., Machiels, J. -P., Lolkema, M., Autio, K., Greil, R., Rottey, S., Adra, N., Salvati, M., Poon, S., Tan, D., Jurida, G., Kouros-Mehr, H., Fizazi, K., Tran, B. & Horvath, L. (2020). PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. [Abstract]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (Suppl 3), pp.A207-A208. https://doi.org/10.1136/jitc-2020-SITC2020.0340Test.; http://hdl.handle.net/11343/273969Test

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية